leukemia, myelogenous, chronic, bcr-abl positive (49)
leukemia, lymphocytic, chronic, b-cell (36)
antineoplastic agents (31)
protein kinase inhibitors (25)
cancer vaccines (16)
pyrimidines (12)
antineoplastic combined chemotherapy protocols (11)
immunotherapy (9)
leukemia, myeloid, chronic-phase (9)
fusion proteins, bcr-abl (8)
histone deacetylases (8)
pyridazines (8)
drug resistance, neoplasm (7)
leukemia, myeloid, chronic (7)
salvage therapy (7)
hematopoietic stem cell transplantation (6)
histone deacetylase inhibitors (6)
imidazoles (6)
lymphoma, large b-cell, diffuse (6)
myelodysplastic syndromes (6)
neoplasms (6)
piperazines (6)
hemic and lymphatic diseases (5)
immunotherapy, adoptive (5)
leukemia, lymphocytic, chronic (5)
leukemia, myeloid, acute (5)
precursor cell lymphoblastic leukemia-lymphoma (5)
t-lymphocytes (5)
wt1 proteins (5)
interleukin-10 (4)
mutation (4)
peptide fragments (4)
skin neoplasms (4)
stat3 transcription factor (4)
antibodies, monoclonal, humanized (3)
antigen-presenting cells (3)
cd4-positive t-lymphocytes (3)
cd8-positive t-lymphocytes (3)
cell transformation, neoplastic (3)
cognitive behavioral therapy (3)
dasatinib (3)
enzyme inhibitors (3)
gene expression regulation (3)
graft vs host disease (3)
heterocyclic compounds (3)
histone deacetylase 6 (3)
leukemia (3)
lymphoma, b-cell (3)
lymphoma, mantle-cell (3)
medicine (general) (3)